Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR8SV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,304
Award facts
- Contract value 100% obligated
- $12,304.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $12,304.46 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on December 3, 2025, with completion by December 4, 2025. This is a firm fixed price, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical prime vendor agreement running through December 2026 that supports military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, has demonstrated substantial capability in supplying brand-name and generic medications, specialty pharmaceuticals, and medical supplies to the Department of Defense and other federal healthcare systems through competitive award processes. The company's portfolio of federal contracts spans multiple therapeutic domains and delivery order values, positioning it as a key provider for military and veteran healthcare needs. Dupixent (dupilumab) is a biologic immunosuppressant used to treat conditions including moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and severe asthma, making this delivery order consistent with DLA's mission to support military medical supply chain requirements.
Quick answers
Who was awarded contract SPE2DR26FR8SV?
SPE2DR26FR8SV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FR8SV worth?
The government has obligated $12,304 on SPE2DR26FR8SV.
Is contract SPE2DR26FR8SV an order under another contract?
Yes. SPE2DR26FR8SV is a delivery order under SPE2DR25D3018, an indefinite delivery contract.
Was contract SPE2DR26FR8SV competed?
The extent of competition for SPE2DR26FR8SV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award